Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/1996
12/04/1996CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions
12/03/1996US5580903 Liver regeneration accelerator
12/03/1996US5580895 1,5-benzodiazepine derivatives
12/03/1996US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics
12/03/1996US5580880 Administering a derivative of spirooxathiolane-quinuclidine
12/03/1996US5580623 Reacting orthophosphoric acid under anhydrous condition with atleast one of calcium carbonate, calcium hydroxide and calcium phosphate to form rapidly setting calcium phophate mineral suitable for bone grafting
11/1996
11/28/1996WO1996037619A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037486A1 (2-morpholinylmethyl)benzamide derivatives
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037210A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
11/28/1996WO1996033277A3 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0743945A1 Heterocyclic compounds and their preparation and use
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743858A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136566A Indole derivatives
11/27/1996CN1136565A Indole derivatives
11/27/1996CN1136432A Indole derivatives
11/27/1996CN1033358C Prodn. method of nutriment from "Xiangyu mushroom"
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578612 Indole derivatives
11/26/1996US5578603 Treatment for alzheimer*s disease, gaastrointrestinal disorders
11/26/1996US5578579 Treatment of gastrointestinal disorders
11/26/1996US5578576 Nutrient solution for reducing side effects of nonsteroidal antiinflammatory drugs
11/26/1996US5578302 Administering a culture of lactobacillus johnsonii
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036644A1 Obesity gene product
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036351A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996WO1996036329A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221314A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996CA2221303A1 Obesity gene product
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/20/1996EP0743321A2 Obesity gene product
11/20/1996EP0743059A2 Process for applying antibacterial oral composition to dental implant areas
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996EP0648108B1 Prophylactic and therapeutical preparation against caries
11/20/1996CN1135898A Chinese medicine for stomach diseases
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/19/1996US5576448 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
11/19/1996US5576437 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
11/19/1996US5576331 Administering 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl) propionic acid or salt
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576323 Excitatory amino acid receptor antagonists
11/19/1996US5576320 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
11/19/1996US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
11/19/1996US5576295 Agent for suppressing the motor activity of gastrointestinal tracts
11/19/1996US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
11/19/1996US5576001 Of carrots, rice, bananas and glucose
11/19/1996US5575652 Process for applying antibacterial oral composition to dental implant areas
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
11/14/1996WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035440A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
11/14/1996WO1996035434A1 Laryngeal bactericidal and antiseptic composition
11/14/1996WO1996035424A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/14/1996WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
11/14/1996DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation
11/14/1996CA2221035A1 Tripeptidylpeptidase inhibitors
11/14/1996CA2220538A1 .beta.-adrenergic agonists
11/14/1996CA2220517A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996CA2220498A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
11/14/1996CA2217860A1 Benzothiazoles and benzoxazoles, pharmaceutical compositions containing these compounds and their use and processes for preparing them
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0742218A1 Pyrrolopyridazine derivative
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741577A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
11/12/1996US5574151 Process for the preparation of sennosides A and B
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996CA2012295C Pyrrolidine derivatives
11/12/1996CA1338711C Ethanone oximes
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034857A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1258